Back
Alnylam Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$326.86
Seasonality Move:
-0.46%
7 Day Trial
ALL ACCESS PASS
$
7
Alnylam Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 23.2% based on the past 21 years of stock performance.
-
Alnylam Pharmaceuticals, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
-
Is Alnylam Pharmaceuticals, Inc. Stock Undervalued?The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $318.65. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 23.2% based on the past 21 years of stock performance.
Alnylam Pharmaceuticals, Inc. Stock Rating
Sell
30
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. overpriced?
-
Alnylam Pharmaceuticals, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
Alnylam Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
495.55
52-Week Low:
205.87
Prediction Charts
Market Cap:
42.3B
Price in USD:
318.65
Volume:
947.6K
Beta:
1.19
Technical Analysis
SMA50:
359.37
SMA100:
404.73
SMA200:
390.18
52-Wk Change:
30.85%
Stock Predictions
-
Is Alnylam Pharmaceuticals, Inc. stock public?Yes, Alnylam Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Alnylam Pharmaceuticals, Inc. stock quote today?The Alnylam Pharmaceuticals, Inc. stock price is 318.65 USD today.
-
How to buy Alnylam Pharmaceuticals, Inc. stock online?You can buy Alnylam Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-11 | 322.14 | 322.28 | 325.04 | 317.80 |
| Feb-12 | 314.42 | 308.48 | 315.51 | 298.00 |
| Feb-13 | 302.55 | 314.40 | 318.44 | 302.55 |
| Feb-17 | 316.80 | 332.61 | 336.21 | 315.63 |
| Feb-18 | 328.86 | 332.68 | 335.80 | 324.53 |
| Feb-19 | 332.24 | 339.37 | 339.61 | 326.33 |
| Feb-20 | 336.58 | 336.19 | 345.90 | 335.83 |
| Feb-23 | 335.73 | 329.35 | 341.39 | 326.76 |
| Feb-24 | 328.22 | 332.85 | 333.07 | 324.48 |
| Feb-25 | 332.76 | 327.36 | 334.42 | 325.24 |
| Feb-26 | 328.67 | 331.24 | 333.47 | 322.00 |
| Feb-27 | 331.24 | 332.92 | 334.80 | 328.39 |
| Mar-2 | 329.41 | 325.07 | 334.42 | 323.16 |
| Mar-3 | 321.37 | 318.65 | 324.06 | 315.20 |
Alnylam Pharmaceuticals, Inc. Earnings
Alnylam Pharmaceuticals, Inc. Earnings Report: Per Share Alnylam Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals, Inc. Forecast Revenue Growth
Alnylam Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.94 per share, an increase next quarter of $0.76 per share, an increase this year of $4.77 per share, and an increase next year of $4.98 per share.
* Alnylam Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.